Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000713555 | SCV000243228 | benign | not provided | 2019-09-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080320 | SCV000633897 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713555 | SCV000844177 | benign | not provided | 2018-04-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317655 | SCV000851244 | likely benign | Inborn genetic diseases | 2016-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000713555 | SCV004160744 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | STXBP1: PP2, BS1, BS2 |
Prevention |
RCV004553037 | SCV004773970 | likely benign | STXBP1-related disorder | 2023-12-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |